Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy
Children with hematological malignancies are at increased risk of hepatitis B virus infection. This study assessed the immunogenicity and safety profile of HBV vaccination in pediatric hemato-oncological children. A nonrandomized interventional study was conducted from January 2017 to February 2020...
Main Authors: | Pengfei Deng, Tian Yang, Hua Zhang, Fen Zhou, Caoyi Xue, Yi Fei, Yijin Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1953303 |
Similar Items
-
Thermoresponsive Polypeptide Fused L‐Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies
by: Sanke Zhang, et al.
Published: (2023-08-01) -
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
by: Suzanne Tavitian, et al.
Published: (2015-08-01) -
A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
by: Zübeyde Nur Özkurt, et al.
Published: (2016-08-01) -
Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies
by: Abdulazeez Adelaja Akinlolu, et al.
Published: (2018-01-01) -
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
by: Maurizio Pompili, et al.
Published: (2015-03-01)